Compounds > 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and fenretinide

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with fenretinide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, WX; Maurer, BJ; O'Donnell, PH; Reynolds, CP	1

Other Studies

1 other study(ies) available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and fenretinide

Article	Year
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. Leukemia, 2002, Volume: 16, Issue:5 Topics: Antineoplastic Agents; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Drug Synergism; Fenretinide; Humans; Lymphocytes; Morpholines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sphingolipids; Time Factors; Tumor Cells, Cultured	2002

Article

Year

N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.

Leukemia, 2002, Volume: 16, Issue:5

Topics: Antineoplastic Agents; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Drug Synergism; Fenretinide; Humans; Lymphocytes; Morpholines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sphingolipids; Time Factors; Tumor Cells, Cultured

2002